{"count": 1, "results": [{"_id": "15350169", "pmid": 15350169, "title": "Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.", "journal": "Expert Rev Cardiovasc Ther", "authors": ["Frishman WH", "Zuckerman AL"], "date": "2004-09-01T00:00:00Z", "doi": "10.1586/14779072.2.5.675", "meta_date_publication": "2004 Sep", "meta_volume": "2", "meta_issue": "5", "meta_pages": "675-81", "score": 50060.375, "text_hl": "Combination therapy of @CHEMICAL_Amlodipine @CHEMICAL_MESH:D017311 @@@amlodipine besylate@@@ (Norvasc, Pfizer Ltd) with @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin calcium@@@ (Lipitor, Pfizer Ltd), marketed as @<m>CHEMICAL_amlodipine_atorvastatin_drug_combination</m> @CHEMICAL_MESH:C487936 @@@Caduet@@@ (Pfizer Ltd) is the first dual-therapy compound designed to treat @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ and/or @<m>DISEASE_Angina_Pectoris</m> @DISEASE_MESH:D000787 @@@angina@@@ and @DISEASE_Dyslipidemias @DISEASE_MESH:D050171 @@@dyslipidemia@@@ concurrently with a single daily pill in the full range of dosing combinations. ", "citations": {"NLM": "Frishman WH, Zuckerman AL. Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease. Expert Rev Cardiovasc Ther. 2004 Sep;2(5):675-81. PMID: 15350169", "BibTeX": "@article{15350169, title={Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.}, author={Frishman WH and Zuckerman AL}, journal={Expert Rev Cardiovasc Ther}, volume={2}, number={5}, pages={675-81}}"}}]}